Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the ana

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which met the ana

BTIG analyst Julian Harrison reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and mainta

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and lowers the

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Ultragenyx stock closed 42% lower on Monday as from Phase 3 studies for setrusumab in OI revealed no

Jefferies analyst Maury Raycroft downgrades Mereo BioPharma Group (NASDAQ:MREO) from Buy to Hold

U.S. stocks fell on Monday, with Nasdaq down 100 points. Nvidia Corp. and Mereo BioPharma Group plc

BTIG analyst Julian Harrison maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and lowers

LifeSci Capital analyst Cory Jubinville downgrades Mereo BioPharma Group (NASDAQ:MREO) from Outpe

Ultragenyx and Mereo BioPharma hit 52-week low after disappointing results from Phase 3 studies for

Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compar

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains

BTIG analyst Julian Harrison reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and mainta

JP Morgan analyst Priyanka Grover maintains Mereo BioPharma Group (NASDAQ:MREO) with a Overweight

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbe

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday.

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on

Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesda